Recent Company News

• 08:45 PM ET Oct 28, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 07:11 PM ET Nov 04, 2026
  

  Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar

• 06:46 PM ET Nov 01, 2026
  

  Mesoblast Board Changes

• 05:06 PM ET Oct 29, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:00 AM ET Oct 29, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:19 PM ET Oct 28, 2026
  

  Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)

• 06:58 PM ET Oct 28, 2026
  

  Mesoblast reports Q1 net cash from / (used in) operating activities ($2.1M) - Appendix 4C (A$1.88, 0.00)

• 07:52 PM ET Oct 27, 2026
  

  Price-Driven Insight from (MESO) for Rule-Based Strategy